$430 million in 2026 spending is projected to more than double to $1.0559 billion by 2036, according to a Future Market Insights forecast for gut immunity enzymes.
9.4% annual growth is tied to buyers shifting from basic ingredient sourcing toward documented enzyme activity, formulation stability and audit-ready batch records for digestive-health products.
Powder is expected to lead product demand with a 37.5% share in 2026, while microbial sources hold 35.0% and beverages account for 41.5% of application demand.
Food manufacturers are projected to represent 35.0% of end-user demand as beverage, dairy and bakery teams seek suppliers that can support commercial trials and retailer approvals.
India is forecast to post the fastest country growth at 8.5%, ahead of China at 7.1%, while mature markets such as the United States are seen expanding more steadily under tighter retail and regulatory scrutiny.